Sodium channel blocker prevents nerves transmitting pain signals
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA). Vertex’s Journavx (suzetrigine), can be used to treat moderate to severe acute pain in adults.